Article Text

Download PDFPDF
Idiopathic fibroadenoma in an elderly man
  1. Jonah Max Cooper1,
  2. Lior Hilsenrath1,
  3. Eva Yagudaev1 and
  4. Wajdi Safadi2
  1. 1Medical School for International Health, Ben-Gurion University of the Negev Faculty of Health Sciences, Beer-Sheva, Southern, Israel
  2. 2Department of Surgery, Clalit Health Services, Golan Heights, Israel
  1. Correspondence to Dr Wajdi Safadi; golancare{at}


A fibroadenoma within the male breast remains a rarely diagnosed entity. Though it was once believed that a fibroadenoma could not exist within a male breast, this has now been demonstrated as incorrect by several reported cases. Most have been in individuals with gynecomastia. There are only a handful of reported cases of men with a diagnosed fibroadenoma in the absence of gynecomastia. We describe a man in his 80s with a left breast fibroadenoma and no features of gynecomastia or hormonal alterations. Based on our findings, we suggest that for men of all ages presenting with a breast lesion, a fibroadenoma remains a possible diagnosis.

  • Breast surgery
  • Pathology

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Contributors The following authors were responsible for drafting of the text, sourcing and editing of clinical images, investigation results, drawing original diagrams and algorithms, and critical revision for important intellectual content: JMC, LH, EY and WS. The following authors gave final approval of the manuscript: JMC, LH, EY and WS.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.